HomeRGT • ASX
add
Argent BioPharma Ltd
Previous close
$0.082
Day range
$0.080 - $0.082
Year range
$0.068 - $0.39
Market cap
5.88M AUD
Avg Volume
102.29K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Prince George Citizen
15 hours ago
S&P/TSX composite down more than 500 points in late-morning trading
1.73%
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 88.14K | -39.54% |
Operating expense | 3.14M | -41.23% |
Net income | -2.84M | 45.64% |
Net profit margin | -3.22K | 10.10% |
Earnings per share | — | — |
EBITDA | -3.40M | 35.30% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.02M | 45.75% |
Total assets | 2.47M | -77.12% |
Total liabilities | 11.10M | -33.20% |
Total equity | -8.63M | — |
Shares outstanding | 72.18M | — |
Price to book | -0.68 | — |
Return on assets | -348.31% | — |
Return on capital | 2,508.18% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -2.84M | 45.64% |
Cash from operations | -2.50M | 25.93% |
Cash from investing | 105.55K | 271.24% |
Cash from financing | 2.55M | 360.23% |
Net change in cash | 153.01K | 105.29% |
Free cash flow | -1.23M | -0.36% |
About
CEO
Founded
2005
Website
